Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artificial Muscle, Inc. is a pioneer in the field of electroactive polymer (EAP) technology, developing actuators and sensors that mimic the properties of natural muscle. Spun off from SRI International, the company's core technology, known as EPAM (Electroactive Polymer Artificial Muscle), provides high-displacement, low-power mechanical motion for a wide range of applications. In the healthcare sector, its technology is applied to haptic feedback systems for robotic surgery, micro-fluidic pumps, and wearable medical devices. The company's materials offer advantages over traditional electromagnetic motors, including lighter weight, silent operation, and greater flexibility. The company was acquired by Bayer MaterialScience in 2010, where its technology was integrated into the ViviTouch brand and broader smart material initiatives. Today, the legacy of its technology continues within Covestro's specialty films and polymers divisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artificial Muscle.